SLC8A1 and malignant colon neoplasm: Inhibiting NCX1/3 and promoting the release of calcium from the endoplasmic reticulum can increase [Ca2+]i, upregulate Ca2+ protein alpha 1D, and promote the migration of HCT116 colon cancer cells [35].